troglitazone has been researched along with Blood Poisoning in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sepsis is associated with impaired PMN function, including chemotaxis." | 1.35 | Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. ( Keshamouni, VG; Milam, JE; Narala, VR; Newstead, MW; Reddy, RC; Standiford, TJ, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, Z | 1 |
| Luo, G | 1 |
| Li, X | 1 |
| Chen, J | 1 |
| Wu, J | 1 |
| Peng, Y | 1 |
| Reddy, RC | 1 |
| Narala, VR | 1 |
| Keshamouni, VG | 1 |
| Milam, JE | 1 |
| Newstead, MW | 1 |
| Standiford, TJ | 1 |
2 other studies available for troglitazone and Blood Poisoning
| Article | Year |
|---|---|
PPARĪ³ inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo.
Topics: 3' Untranslated Regions; Animals; Cells, Cultured; Chromans; HMGB1 Protein; Humans; Interleukin-6; L | 2016 |
Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}.
Topics: Actins; Anilides; Animals; Antineoplastic Agents; Cell Adhesion; Chemotaxis; Chromans; Disease Model | 2008 |